Stock Market

(Image: QuintilesIMS)

Quintiles, IMS merger completed

By Melissa Fassbender

IMS Health has completed its merger with Quintiles, forming QuintilesIMS – one of the world’s largest healthcare information portfolios.

(Image: iStock)

Quintiles, IMS Health merge

By Melissa Fassbender

Quintiles and IMS Health have merged to form Quintiles IMS Holdings, effectively creating one of the world’s largest healthcare information portfolios.

WuXi to go private as part of $3.3bn deal

WuXi to go private as part of $3.3bn deal

By Zachary Brennan

A group of investors, shareholders and executives of China-based CDMO WuXi are taking the company private in a deal worth about $3.3bn.

Tigermed Envy? WuXi may be eyeing a launch on Shenzhen exchange

Tigermed Envy? WuXi may be eyeing a launch on Shenzhen exchange

By Zachary Brennan

With WuXi pushing full steam ahead in its bid to go private, one expert says that the company may be envious of a competing CRO -- Hangzhou Tigermed, which is smaller than WuXi but valued at a higher price on the Shenzhen stock exchange.

Covance shareholders sign off on LabCorp merger

Covance shareholders sign off on LabCorp merger

By Zachary Brennan

CRO Covance's stockholders voted Wednesday to adopt the previously announced $6.1bn merger agreement providing for the acquisition of Covance by LabCorp at the special meeting of Covance stockholders. 

Parexel predicts 10% revenue growth for FY2015

Parexel predicts 10% revenue growth for FY2015

By Fiona Barry

Parexel has predicted ten per cent year-on-year revenue growth for FY2015 but has been more modest about its operating margins ahead of its Investor Day tomorrow.

Recipharm confirms IPO plan

breaking news - update 1

Recipharm confirms plans to list on OMX

By Gareth Macdonald

Recipharm has confirmed that it is making plans to go public this year, citing a desire to finance “rapid growth” and acqusitions as the motivation.

'Moody' Analysts Upbeat About Quintiles

'Moody' Analysts Upbeat About Quintiles

By Dan Stanton

Analysts from rating agency Moody's have upgraded their view of Quintiles, the world’s “largest pharmaceutical service provider,” from stable to positive.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers